BL PharmTech Corp
KOSDAQ:065170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BL PharmTech Corp
Net Change in Cash
BL PharmTech Corp
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BL PharmTech Corp
KOSDAQ:065170
|
Net Change in Cash
₩603.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
|
|
AmorePacific Corp
KRX:090430
|
Net Change in Cash
₩73B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-14%
|
|
|
Amorepacific Group
KRX:002790
|
Net Change in Cash
₩32.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
|
Cosmax Inc
KRX:192820
|
Net Change in Cash
-₩64.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Net Change in Cash
-₩167.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Net Change in Cash
₩83.4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
BL PharmTech Corp
Glance View
BL Pharmtech Corp. engages in health food industry. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2002-11-19. The firm operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.
See Also
What is BL PharmTech Corp's Net Change in Cash?
Net Change in Cash
603.5m
KRW
Based on the financial report for Sep 30, 2025, BL PharmTech Corp's Net Change in Cash amounts to 603.5m KRW.
What is BL PharmTech Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-20%
